Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine adjuvants

R Edelman

    Reviews of Infectious Diseases
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Future viral vaccines may require immune-boosting adjuvants to enhance effectiveness and reduce antigen needs. Overcoming safety concerns is crucial for developing these potent adjuvanted vaccines.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Twofold improved tumor-to-brain contrast using a novel T1 relaxation-enhanced steady-state (T<sub>1</sub>RESS) MRI technique.

    Science advances·2020
    Same author

    Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.

    The Journal of hospital infection·2016
    Same author

    Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

    Science (New York, N.Y.)·2011
    Same author

    Benign cardiac tumours: cardiac CT and MRI imaging appearances.

    Journal of medical imaging and radiation oncology·2009
    Same author

    Abdominal ultra sonographic findings detected in the course of a hepatitis survey in an Egyptian rural area.

    The Journal of the Egyptian Public Health Association·2007
    Same author

    Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia.

    The Journal of hospital infection·2004
    Same journal

    Fatal necrotizing otitis externa in a patient with AIDS.

    Reviews of infectious diseases·1991
    Same journal

    Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.

    Reviews of infectious diseases·1991
    Same journal

    A new case of meningitis due to Pasteurella multocida.

    Reviews of infectious diseases·1991
    Same journal

    Disseminated pelvic actinomycosis presenting as metastatic carcinoma: association with the progestasert intrauterine device.

    Reviews of infectious diseases·1991
    Same journal

    Genetically engineered attenuated herpes simplex viruses.

    Reviews of infectious diseases·1991
    Same journal

    Role of altered drug metabolism in virus-drug interactions.

    Reviews of infectious diseases·1991
    See all related articles

    Area of Science:

    • Vaccinology
    • Immunology
    • Biotechnology

    Background:

    • Future nonreplicating viral vaccines (subunit or synthetic) are expected to be weak immunogens.
    • These vaccines may require immunopotentiation for efficacy.
    • Adjuvants can enhance vaccine effectiveness and reduce antigen requirements, improving feasibility and economics.

    Purpose of the Study:

    • To explore the potential of immunologic adjuvants in improving weak viral vaccines.
    • To discuss the role of synthetic immunoregulators in modulating immune responses.
    • To address the critical issue of adjuvant safety in vaccine development.

    Main Methods:

    • Review of current understanding of vaccine immunogenicity.
    • Discussion of potential adjuvant candidates, including synthetic immunoregulators.

    Related Experiment Videos

  • Analysis of safety concerns and experimental requirements for adjuvanted vaccines.

    • Main Results:

    • Adjuvants can significantly improve the immunogenicity of subunit and synthetic viral vaccines.
    • Synthetic immunoregulators offer a potential mechanism for modulating specific immune compartments.
    • Adjuvant safety remains a significant unresolved challenge for vaccine development.

    Conclusions:

    • Adjuvanted vaccines hold promise for enhancing vaccine efficacy and reducing production costs.
    • Overcoming safety concerns through rigorous research and clear guidelines is essential for the advancement of adjuvanted vaccines.
    • Further experimentation is needed to ensure the safety and efficacy of adjuvants in human studies.